Abstract: A new modification of torasemide, named modification III, has been discovered. Modification III is storage stable and achieves high levels in serum shortly after oral administration. Torasemide of modification III can be used to produce a diuretic effect. A method of making torasemide of modification III is disclosed.
Type:
Grant
Filed:
June 2, 1998
Date of Patent:
December 26, 2000
Assignee:
Roche Diagnostics GmbH
Inventors:
Bruno Dreckmann-Behrendt, Artur Burger, Judith M. Rollinger